Ketamine Therapy Test: Should You Seek a Specialist Assessment?

Ketamine is an established anaesthetic and analgesic medicine. In mental health care, ketamine-based treatments may be considered in selected clinical settings, particularly for some adults whose depression has not improved with standard treatment. A brief online screening cannot determine whether treatment is appropriate for you.

This test reviews your symptoms, treatment history, basic safety factors, and local availability. It does not diagnose any condition, and it does not replace a full medical and psychiatric assessment.

Next steps

Your results are not medical advice and not a green light to begin ketamine treatment. They are only a screening summary. If your result suggests that further assessment may be worth exploring, the next step is to speak with a qualified clinician. You may then:

— review your diagnosis, symptoms, and treatment history

— discuss medical checks, risks, and possible contraindications

— learn about dosing, administration, monitoring, and follow-up

You can use the States of Mind provider directory to identify reputable local providers.

Ketamine-based treatments are not first-line care for most psychiatric conditions. The evidence is still evolving, and regulatory approval depends on the country and the indication. In the United States, esketamine nasal spray is approved for adults with treatment-resistant depression and for depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behaviour, under supervised clinical use. This screening page is based on selected guidelines and reviews, but it cannot replace clinician assessment. Ketamine-based treatments and conventional antidepressants work differently and are used in different clinical contexts. Some ketamine-based treatments may act more quickly than standard antidepressants, but they also require supervised use, careful screening, and monitoring. This test should not be used to compare treatments or predict response.